Research / NVT / Fundamental state Inspectable configuration
State dimensions Filing 0001720635-22-000052 General Corporate
Debt relative to revenue 28th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.debt_to_revenue
143.81% · OPTIONAL · VALID
Share-count growth 64th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.shares_outstanding
-0.98% · CORE · VALID
Revenue growth 64th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
15.93% · CORE · VALID
Inventory pressure 89th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
50.25% · OPTIONAL · VALID
Gross margin 50th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_margin
38.92% · CORE · VALID
Operating margin 94th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.operating_margin
16.17% · CORE · VALID
R&D intensity 6th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.97% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 10/10 normalized Level 3 Dec 31, 2021 10/10 normalized Level 3 Mar 31, 2022 10/10 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 10/10 normalized Level 3 Mar 31, 2023 10/10 normalized Level 3 Jun 30, 2023 10/10 normalized Level 3 Sep 30, 2023 10/10 normalized Level 3 Dec 31, 2023 10/10 normalized Level 3 Mar 31, 2024 10/10 normalized Level 3 Jun 30, 2024 10/10 normalized Level 3 Sep 30, 2024 10/10 normalized Level 3 Dec 31, 2024 10/10 normalized Level 3 Mar 31, 2025 10/10 normalized Level 3 Jun 30, 2025 10/10 normalized Level 3 Sep 30, 2025 10/10 normalized Level 3 Dec 31, 2025 10/10 normalized Level 3 Mar 31, 2026 10/10 normalized Level 3 Jun 30, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 143.40%
Current 143.81%
Delta 0.42% Dilution Decreased
Previous -0.96%
Current -0.98%
Delta -0.02% Growth Decreased
Previous 20.99%
Current 15.93%
Delta -5.06% Inventory Pressure Decreased
Previous 51.60%
Current 50.25%
Delta -1.35% Margin Increased
Previous 36.81%
Current 38.92%
Delta 2.10% Profitability Increased
Previous 14.39%
Current 16.17%
Delta 1.78% R And D Intensity Decreased
Previous 2.01%
Current 1.97%
Delta -0.03% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.